Live talk

Join us Thursday, January 26, at 3:00 pm PST, for a lively discussion on issues affecting pituitary medicine and patients.  The recorded session will be available on-demand following our live program.

Read more about Live Talk here  –  Listen to our past sessions on demand.

News In Brief

Recordati Rare Diseases Introduces Cushing’s Conversations, a new support program for people who have been prescribed  ISTURISA®.   Read more

Crinetics Pharmaceuticals announces enrollment is complete in the placebo-controlled Phase 3 PATHFNDR-1 study evaluating the safety and efficacy of once-daily oral #paltusotine in #acromegaly patients. Read more

Amryt Pharma relaunches its patient-facing website for Mycapssa

Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome.  Click here to learn more and see if you qualify. 

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

The ongoing debates and nomenclature change and reclassification are apparently over, and adenomas and now referred to as Pit-Net's (pituitary neuroendocrine tumors).  Is this good, bad, or indifferent?  These are complicated matters, so to shed some more light on the subject, we've invited some experts to discuss them.  

In today's podcasts, Dr. Blevins talks about the genesis of pseudo Cushing's syndrome and illustrates a fascinating case of pseudo Cushing's syndrome due to alcohol ingestion.

Subscribe & Listen

Live Talk on Demand